1. From: Pharmacologic Therapy for Type 2 Diabetes Mellitus
Ann Intern Med. 1999;131(4): doi: /
Figure Legend:
Pathogenesis of type 2 diabetes mellitus.
Date of download: 10/20/2017
Copyright © American College of Physicians. All rights reserved.

2. From: Pharmacologic Therapy for Type 2 Diabetes Mellitus
Ann Intern Med. 1999;131(4): doi: /
Figure Legend:
Time-related change in median fasting plasma glucose level (left) and median hemoglobin A(HbA) (right) in patients with type 2 diabetes treated with sulfonylureas (triangles), metformin (diamonds), insulin (squares), or conventional (diet) therapy (circles).
Date of download: 10/20/2017
Copyright © American College of Physicians. All rights reserved.

3. From: Pharmacologic Therapy for Type 2 Diabetes Mellitus
Ann Intern Med. 1999;131(4): doi: /
Figure Legend:
Effect of conventional treatment with diet (bold solid line), intensive treatment with sulfonylureas or insulin (solid line), and metformin therapy (dashed line) on any diabetes-related end point (top left), diabetes-related death (bottom left), microvascular complications (top right), and myocardial infarction (bottom right).P
Date of download: 10/20/2017
Copyright © American College of Physicians. All rights reserved.

4. From: Pharmacologic Therapy for Type 2 Diabetes Mellitus
Ann Intern Med. 1999;131(4): doi: /
Figure Legend:
Pharmacologic algorithm for treatment of patients in whom type 2 diabetes is inadequately controlled with diet and exercise.
Date of download: 10/20/2017
Copyright © American College of Physicians. All rights reserved.